Skip to main content
. 2022 Sep 23;101(38):e30823. doi: 10.1097/MD.0000000000030823

Table 1.

Clinical and surgery-related data of the groups.

Group 1 (n = 72) Group 2 (n = 52) Control group (n = 58) P value *
Age ± SD (yr) 62.89 ± 7.60 61.42 ± 8.72 65.11 ± 8.80 .312
Gender
 Male 19 13 16 .955
 Female 53 39 42
Side L:Left, R: Right, Bil : Bilateral (L/R/Bil) 27/32/13 20/17/15 28/14/16 .064
Height ± SD (m) 1.54 ± 0.12 1.53 ± 0.09 1.58 ± 0.31 .114
Weight ± SD (kg) 65.49 ± 10.50 62.76 ± 11.95 63.64 ± 9.50 .189
BMI ± SD (kg/m2) 26.06 ± 3.78 25.22 ± 3.94 26.54 ± 4.41 .228
Operative time ± SD (min) 95.12 ± 37.16 91.76 ± 25.83 90.35 ± 40.22 .330
Preoperative mean
 Hgb (g/dL) 12.62 ± 1.88 12.61 ± 1.35 12.80 ± 1.40 .764
 Hct 39.05 ± 5.01 38.11 ± 3.60 38.43 ± 3.73 .451
Postoperative mean
 Hgb (g/dL) 10.53 ± 1.28 11.10 ± 1.49 10.47 ± 1.24 .027*
 Hct 32.45 ± 3.90 33.53 ± 4.19 31.47 ± 3.52 .022*
Δ Hgb 2.08 ± 1.34 1.50 ± 1.50 2.32 ± 0.98 .001*
Δ Hct 6.60 ± 3.96 4.57 ± 2.73 6.96 ± 2.81 .001*
HBL (mL) 275.75 ± 151.14 257.13 ± 61.14 339.50 ± 101.84 .001*
VBL (mL) 389.60 ± 186.2 331.52 ± 96.7 396.80 ± 114.8 .001*
TBL (mL) 665.66 ± 121.76 588.65 ± 100.18 736.35 ± 272.81 .001*
Length of stay (d) 6.01 ± 3.37 4.77 ± 1.84 5.48 ± 1.85 .024*

Bil. = Bilateral, BMI = body mass index, HBL = hidden blood loss, Hct = hematocrit, Hgb = hemoglobin, L = Left, R =Right, SD = standard deviation, TBL = total blood loss, VBL = visible blood loss.

*

One-way ANOVA analysis.